The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases

INTRODUCTION: Minimal residual disease (MRD) is commonly assessed in bone marrow (BM) aspirate. However, sample quality can impair the MRD measurement, leading to underestimated residual cells and to false negative results. To define a reliable and reproducible method for the assessment of BM hemodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigliotta, Ilaria, Armuzzi, Silvia, Barone, Martina, Solli, Vincenza, Pistis, Ignazia, Borsi, Enrica, Taurisano, Barbara, Mazzocchetti, Gaia, Martello, Marina, Poletti, Andrea, Sartor, Chiara, Rizzello, Ilaria, Pantani, Lucia, Tacchetti, Paola, Papayannidis, Cristina, Mancuso, Katia, Rocchi, Serena, Zamagni, Elena, Curti, Antonio, Arpinati, Mario, Cavo, Michele, Terragna, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582597/
https://www.ncbi.nlm.nih.gov/pubmed/36276072
http://dx.doi.org/10.3389/fonc.2022.1001048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582597/
https://www.ncbi.nlm.nih.gov/pubmed/36276072
http://dx.doi.org/10.3389/fonc.2022.1001048

Ejemplares similares